Tirbanibulin
Tirbanibulin, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
| Trivial name | KX 01 |
| Catalog Number | S2700 |
| Molecular Formula | C39H67N5O7 |
| CAS# | 897016-82-9 |
| Inchi | InChI=1S/C39H67N5O7/c1-13-25(6)34(43(10)39(49)33(24(4)5)42-38(48)32(40-9)23(2)3)30(50-11)22-31(45)44-21-17-20-29(44)36(51-12)26(7)37(47)41-27(8)35(46)28-18-15-14-16-19-28/h14-16,18-19,23-27,29-30,32-3 6,40,46H,13,17,20-22H2,1-12H3,(H,41,47)(H,42,48)/t25-,26+,27+,29-,30+,32-,33-,34-,35+,36+/m0/s1 |
| Inchi Key | DASWEROEPLKSEI-UIJRFTGLSA-N |
| SMILES | CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(C)C(C2=CC=CC=C2)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/kx2-391.html |
| Additional Information | https://file.selleck.cn/downloads/struct/KX2-391-chemical-structure-s2700.gif |